Benzinga | Aug 3, 2021 07:00AM EDT

Bausch Health Companies Q2 GAAP Net Loss $595M, Adj. EBITDA $826M, Sales $2.10B Miss $2.12B Estimate; Cuts Guidance

Bausch Health Companies (NYSE:BHC) reported quarterly sales of $2.10 billion which missed the analyst consensus estimate of $2.12 billion by 0.94 percent. This is a 26.20 percent increase over sales of $1.66 billion the same period last year.